249420.KS
Ildong Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 15,100.00
−8.43%Margins
Gross margin
38.4%
EBITDA margin
-0.9%
EBIT margin
4.4%
Net margin
7.5%
FCF margin
4.1%
16.9%
Return on equity
7.8%
Return on assets
6.4%
Return on invested capital
1.04x
Asset turnover
KRW 35.4B
Cash from operations
KRW 2.0K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026